Literature DB >> 17250446

Hodgkin's lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore.

Neelam Siddiqui1, Bilal Ayub, Farhana Badar, Alia Zaidi.   

Abstract

OBJECTIVES: To study the clinico-epidemiological profile of Hodgkin's lymphoma (HL) in Pakistan. PATIENTS AND METHODS: We retrospectively studied all histopathologically proven cases of HL, who presented between Dec 1995 to June 2003 at Shaukat Khanum Memorial Cancer Hospital and Research Hospital (SKMCH & RC). All the relevant information was obtained through the hospital based cancer registry and medical records of the selected patients.
RESULTS: Six hundred and fifty eight histopathologically confirmed cases of HL were identified. There were 505 males and 153 females, with a male to female ratio of 3.3: 1. Patients ranged in age from 1 year - 84 years. The mean age at presentation was 23.8 years. Three hundred and twenty cases (48.6%) belonged to age group <or= 18 years and 338 cases (51.4%) were > 18 years of age. Histopathologically, mixed cellularity (MC) constituted 63.8% of cases, followed by nodular sclerosis (NS) 19.9%, lymphocyte predominant (LP) 7.3% and lymphocyte depleted (LD) 1.2%. Early stage (stage I and II) disease was present in 43.9% of patients at presentation, while 56.1% patients presented with advanced stage (stage III and IV). The majority of patients (81.2%) presented with cervical lymphadenopathy.
CONCLUSION: The clinico-epidemiological pattern of Hodgkin's lymphoma in Pakistan manifested is similar to that observed in other developing countries, with male predominance, mixed cellularity as the commonest histological type, advanced stage at presentation and absence of bimodal age distribution.

Entities:  

Mesh:

Year:  2006        PMID: 17250446

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Clinicopathological Spectrum of Hodgkin's and Non-Hodgkin's Lymphoma: A Tertiary Care Cancer Hospital Study in Pakistan.

Authors:  Wardah Aslam; Maryam Habib; Saeeda Aziz
Journal:  Cureus       Date:  2022-06-03

2.  Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.

Authors:  Diponkar Banerjee
Journal:  Adv Hematol       Date:  2011-01-18

3.  Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters.

Authors:  Atif Ali Hashmi; Zubaida Fida Hussain; Kashif Ali Hashmi; Muhammad Irfan Zafar; Muhammad Muzzammil Edhi; Naveen Faridi; Mehmood Khan
Journal:  World J Surg Oncol       Date:  2017-04-20       Impact factor: 2.754

4.  Applicability of protocols from high-income countries in a resource limited setting; real world data of histopathology, clinical features and long-term outcome of Hodgkin Lymphoma in Sri Lanka.

Authors:  Saman Hewamana; Lakmali Kandabadage; Thurairajah Skandarajah; Natasha Peiris; Sobitha Abeyaratne; Gehan Arseculeratne; Eranga Perera; Mahesh Harischandra; Ananda Wijewickrama; Gnani Somasundaram; Vadivelu Srinivasan; Surjit Somiah; Priyankara Jayawardena; Rohini Wadanamby; Geethani Galagoda; Chathuri Jayasinghe; Chandu De Silva; Sanjeewa Munasinghe; Bandula Wijesiriwardena; Jayantha Balawardena
Journal:  EClinicalMedicine       Date:  2021-07-06

5.  Registration of cancer in girls remains lower than expected in countries with low/middle incomes and low female education rates.

Authors:  S S Bhopal; K D Mann; M S Pearce
Journal:  Br J Cancer       Date:  2012-05-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.